Currently, expression levels of ATRX, MGMT, FLT1, GFAP, MKi67, NES, OLIG2, S1001A, VIM and PIK3CA are used in the clinic for patient GBM diagnosis and prognosis. Here, ATRX is linked to glioblastoma.